ATE168132T1 - Strukturgen von pneumokokken-protein - Google Patents

Strukturgen von pneumokokken-protein

Info

Publication number
ATE168132T1
ATE168132T1 AT92907062T AT92907062T ATE168132T1 AT E168132 T1 ATE168132 T1 AT E168132T1 AT 92907062 T AT92907062 T AT 92907062T AT 92907062 T AT92907062 T AT 92907062T AT E168132 T1 ATE168132 T1 AT E168132T1
Authority
AT
Austria
Prior art keywords
nucleic acid
pneumococcal protein
structure genes
pspa
genes
Prior art date
Application number
AT92907062T
Other languages
English (en)
Inventor
David E Briles
Janet L Yother
Larry S Mcdaniel
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Application granted granted Critical
Publication of ATE168132T1 publication Critical patent/ATE168132T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92907062T 1991-02-15 1992-02-12 Strukturgen von pneumokokken-protein ATE168132T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65677391A 1991-02-15 1991-02-15

Publications (1)

Publication Number Publication Date
ATE168132T1 true ATE168132T1 (de) 1998-07-15

Family

ID=24634503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907062T ATE168132T1 (de) 1991-02-15 1992-02-12 Strukturgen von pneumokokken-protein

Country Status (15)

Country Link
US (1) US5728387A (de)
EP (2) EP0571538B1 (de)
JP (3) JP3215109B2 (de)
AT (1) ATE168132T1 (de)
AU (1) AU692678C (de)
CA (1) CA2104014C (de)
DE (1) DE69226167T2 (de)
DK (1) DK0571538T5 (de)
ES (1) ES2118812T3 (de)
FI (1) FI933580A7 (de)
IE (2) IE20000062A1 (de)
IL (1) IL100946A0 (de)
NO (1) NO313999B1 (de)
WO (1) WO1992014488A1 (de)
ZA (1) ZA921025B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965141A (en) * 1991-02-15 1999-10-12 Uab Research Foundation Epitopic regions of pneumococcal surface protein a
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US6231870B1 (en) * 1995-06-02 2001-05-15 Uab Research Foundation Oral administration of pneumoccal antigens
US6592876B1 (en) 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6232116B1 (en) 1991-02-15 2001-05-15 University Of Alabama At Birmingham Research Foundation Oral administration of pneumococcal antigens
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
AU734488B2 (en) * 1994-05-20 2001-06-14 Uab Research Foundation Mucosal administration of pneumococcal antigens
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US6004802A (en) * 1995-06-02 1999-12-21 University Of Alabama At Birmingham Oral administration of pneumococcal antigens
EP0871479A2 (de) * 1995-06-02 1998-10-21 The Uab Research Foundation Orale verabreichung von pneumokokken-antigenen
EA199800046A1 (ru) * 1995-06-07 1998-06-25 Байокем Вэксинс Инк. Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
PT832093E (pt) * 1995-06-07 2006-12-29 Sanofi Pasteur Inc Expressão de lipoproteínas
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
ZA964896B (en) 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US7078042B2 (en) 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US5949537A (en) 1996-04-18 1999-09-07 American Air Liquide Inc. In-line cell for absorption spectroscopy
US6165989A (en) * 1996-05-14 2000-12-26 Smithkline Beecham Corporation Era of Streptococcus pneumoniae
EP0979101B1 (de) 1996-07-03 2010-10-27 Merial, Inc. Rekombinanter hunde-adenovirus 2 (cav2), welcher exogene dna enthält
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
ZA9710934B (en) * 1996-12-04 1998-09-10 Univ Alabama Compositions and methods for administering pneumococal dna
KR19980067137A (ko) * 1997-01-31 1998-10-15 박원훈 알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
AU9574598A (en) * 1997-09-18 1999-04-05 Pasteur Merieux Connaught Improved method of production of pneumococcal surface proteins
US6224882B1 (en) 1997-11-07 2001-05-01 Protein Science Corp. Insect cells or fractions as adjuvant for antigens
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
EP1246935B1 (de) 1999-09-28 2013-08-14 Geneohm Sciences Canada Inc. Konservierte gene und dessen benutzung für die herstellung von sonden und primern für mikroorganismen nachweis
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
AT410412B (de) 2000-11-10 2003-04-25 Inteco Int Techn Beratung Verfahren zum elektroschlacke umschmelzen von metallen
EP2275122A3 (de) * 2002-04-02 2011-05-18 Ben Gurion University Of The Negev Research And Development Authority Streptococcus-pneumoniae-Vakzine auf Proteinbasis
US8691243B2 (en) 2002-04-02 2014-04-08 Ben-Gurion University Of The Negev Research And Development Authority Protein-based Streptococcus pneumoniae vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
KR101515078B1 (ko) 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
MY150105A (en) 2006-01-17 2013-11-29 Forsgren Arne A novel surface exposed haemophilus influenzae protein (protein e; pe)
CA2690708A1 (en) 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine
ES2553113T3 (es) 2008-04-16 2015-12-04 Glaxosmithkline Biologicals S.A. Vacuna
EP2711021B1 (de) 2008-05-02 2016-03-09 BliNK Therapeutics Limited Produkte und Verfahren zur Stimulation einer Immunantwort
EP2545071A2 (de) 2010-03-09 2013-01-16 Maksyutov, Amir Polyepitopkonstrukte sowie verfahren zu ihrer herstellung und verwendung
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
AU2011252844B2 (en) 2010-05-14 2014-07-03 Baxalta GmbH Chimeric OspA genes, proteins, and methods of use thereof
US9109007B2 (en) 2010-08-18 2015-08-18 Purdue Pharma L.P. MHC-I restricted epitopes containing non-natural amino acid residues
CN103533953A (zh) 2011-05-17 2014-01-22 葛兰素史密丝克莱恩生物有限公司 针对肺炎链球菌的疫苗
AU2013293448A1 (en) 2012-07-27 2015-02-05 Baxalta GmbH Compositions comprising chimeric OspA molecules and methods of use thereof
CN104812405A (zh) 2012-09-19 2015-07-29 国立大学法人大阪大学 含有肺炎球菌表面蛋白a的肺炎球菌疫苗
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
CN110381992A (zh) * 2016-12-03 2019-10-25 Uab研究基金会 组合了肺炎球菌表面蛋白A的选择的α螺旋结构域和脯氨酸富集结构域的肺炎球菌疫苗
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
GB201711635D0 (en) 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
CN110499375B (zh) * 2019-08-28 2023-03-28 首钢医院有限公司 结合多交叉置换扩增和金纳米检测肺炎链球菌的方法
KR20250035053A (ko) 2022-06-07 2025-03-11 리제너론 파아마슈티컬스, 인크. T 세포 활성을 조절하기 위한 다중특이적 분자 및 이의 용도
EP4536836A1 (de) 2022-06-07 2025-04-16 Regeneron Pharmaceuticals, Inc. Pseudotypisierte virale partikel zum targeting von tcr-exprimierenden zellen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine

Also Published As

Publication number Publication date
DE69226167D1 (de) 1998-08-13
IE920479A1 (en) 1992-08-26
DE69226167T2 (de) 1998-11-12
IL100946A0 (en) 1992-11-15
JP2001204482A (ja) 2001-07-31
IE20000062A1 (en) 2000-12-13
FI933580L (fi) 1993-10-13
FI933580A0 (fi) 1993-08-13
NO313999B1 (no) 2003-01-13
NO932890D0 (no) 1993-08-13
AU692678B2 (en) 1998-06-11
DK0571538T5 (da) 2002-03-04
CA2104014A1 (en) 1992-08-16
US5728387A (en) 1998-03-17
WO1992014488A1 (en) 1992-09-03
AU667668B2 (en) 1996-04-04
EP0786521A1 (de) 1997-07-30
JPH09224680A (ja) 1997-09-02
EP0571538B1 (de) 1998-07-08
EP0571538A1 (de) 1993-12-01
ES2118812T3 (es) 1998-10-01
DK0571538T3 (da) 1999-04-19
JPH06504446A (ja) 1994-05-26
AU692678C (en) 2002-08-29
CA2104014C (en) 2000-05-02
HK1013629A1 (en) 1999-11-26
JP3215109B2 (ja) 2001-10-02
AU4798096A (en) 1996-06-27
FI933580A7 (fi) 1993-10-13
NO932890L (no) 1993-10-14
ZA921025B (en) 1992-11-25
EP0571538A4 (en) 1994-08-24
AU1445392A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
ATE168132T1 (de) Strukturgen von pneumokokken-protein
ATE112802T1 (de) Herstellung von funktionellen menschlichen urokinasepolypeptiden.
DK0666914T3 (da) Hidtil ukendt P-selectin-ligandprotein
OA09116A (en) Novel protein, sequences containing the gene therefore vectors, methods of preparation and use.
DK346385A (da) Genetiske sekvenser, hermed kodede interferon-peptider af type i og organismer, der producerer disse
DE69121975D1 (de) Spezifischer Nachweis von Mycobacterium Tuberculosis
BG50281A3 (bg) Метод за получаване на рекомбинантн днк експресионен вектор
ATE140971T1 (de) Verfahren zur herstellung von clavulanic säure
IL88963A0 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
IT8621312A0 (it) Procedimento di (co)polimerizzazioni di alfa olefine in presenta di stabilizzanti.
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0293079A3 (de) Chlamydia-Vakzin
EA199900256A1 (ru) Нуклеотидная и белковая последовательность маммастатина и способы применения
NO934166D0 (no) Fremgangsm}te for fremstilling av sulfonerte parafiner, samt anvendelse av et salt derav
ATE112803T1 (de) Dns-klonierungsvektor mit in vivo ausschneidbaren plasmiden.
ATE80658T1 (de) Herstellung von cyanid-hydratase.
DE3856392D1 (de) Klonierung von Malaria-spezifischen DNA-Sequenzen:Isolierung des Gens für das 140 kd Protein
FI872031A7 (fi) Streptokinaasin tuottaminen DNA-tekniikalla saadulla hiivalla.
ES2086374T3 (es) Vectores de expresion de adn recombinante y compuestos de adn que codifican la actividad aciltransferasa de aspergillus.
ATE111527T1 (de) Herstellung und verwendung einer dna zur erhöhung der ausbeute bei der expression von rekombinanten genen.
IT1230519B (it) Miscela di caucciu' reticolabile, in particolare vulcanizzabile mediante zolfo.
ES2061574T3 (es) Acil-peptido-hidrolasa y metodos de produccion y uso.
FI920030A7 (fi) IBDV-proteiiniin liittyviä spesifisiä DNA-sekvenssejä sekä vektoreita, isäntiä ja rokotteita
ATE42552T1 (de) Verfahren zur herstellung von 2.3dichlorthiophen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee